GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianyin Pharmaceutical Co Inc (GREY:TPIY) » Definitions » EV-to-EBIT

Tianyin Pharmaceutical Co (Tianyin Pharmaceutical Co) EV-to-EBIT : -0.03 (As of May. 18, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Tianyin Pharmaceutical Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tianyin Pharmaceutical Co's Enterprise Value is $0.16 Mil. Tianyin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2015 was $-5.11 Mil. Therefore, Tianyin Pharmaceutical Co's EV-to-EBIT for today is -0.03.

The historical rank and industry rank for Tianyin Pharmaceutical Co's EV-to-EBIT or its related term are showing as below:

TPIY's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.96
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tianyin Pharmaceutical Co's Enterprise Value for the quarter that ended in Mar. 2015 was $2.64 Mil. Tianyin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2015 was $-5.11 Mil. Tianyin Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2015 was -193.50%.


Tianyin Pharmaceutical Co EV-to-EBIT Historical Data

The historical data trend for Tianyin Pharmaceutical Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianyin Pharmaceutical Co EV-to-EBIT Chart

Tianyin Pharmaceutical Co Annual Data
Trend Dec05 Dec06 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only 2.34 0.69 -1.10 -0.65 -44.00

Tianyin Pharmaceutical Co Quarterly Data
Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -44.00 -7.81 -3.93 -0.52

Competitive Comparison of Tianyin Pharmaceutical Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Tianyin Pharmaceutical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianyin Pharmaceutical Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianyin Pharmaceutical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tianyin Pharmaceutical Co's EV-to-EBIT falls into.



Tianyin Pharmaceutical Co EV-to-EBIT Calculation

Tianyin Pharmaceutical Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.160/-5.108
=-0.03

Tianyin Pharmaceutical Co's current Enterprise Value is $0.16 Mil.
Tianyin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianyin Pharmaceutical Co  (GREY:TPIY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tianyin Pharmaceutical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2015 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2015 ) =EBIT / Enterprise Value (Q: Mar. 2015 )
=-5.108/2.63976
=-193.50 %

Tianyin Pharmaceutical Co's Enterprise Value for the quarter that ended in Mar. 2015 was $2.64 Mil.
Tianyin Pharmaceutical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianyin Pharmaceutical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tianyin Pharmaceutical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianyin Pharmaceutical Co (Tianyin Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
South Renmin Road, Unionsun Yangkuo Plaza, 23rd Floor, No. 2, Block 3, Sichuan, Chengdu, CHN, 610041
Tianyin Pharmaceutical Co Inc along with its subsidiaries is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals. The medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The business activities are primarily carried out through the region of China.

Tianyin Pharmaceutical Co (Tianyin Pharmaceutical Co) Headlines

From GuruFocus

8 Healthcare Dividend Stocks Close To 52-Week Low

By Dividend Dividend 09-03-2011